109 related articles for article (PubMed ID: 9310083)
41. Markers of inflammation in women on different hormone replacement therapies.
Fröhlich M; Mühlberger N; Hanke H; Imhof A; Döring A; Pepys MB; Koenig W
Ann Med; 2003; 35(5):353-61. PubMed ID: 12952022
[TBL] [Abstract][Full Text] [Related]
42. The effect of hormonal replacement therapy on the vascular reactivity and endothelial function of healthy individuals and individuals with type 2 diabetes.
Lim SC; Caballero AE; Arora S; Smakowski P; Bashoff EM; Brown FM; Logerfo FW; Horton ES; Veves A
J Clin Endocrinol Metab; 1999 Nov; 84(11):4159-64. PubMed ID: 10566666
[TBL] [Abstract][Full Text] [Related]
43. [Thrombophilic syndrome associated to phenotypic resistance to activated protein C in postmenopausal women].
Caserta L; Caserta R; Torella M; Perricone F; Nesti E; Sessa M; Tagliaferri A; De Francesco F; De Lucia D; Panariello S
Minerva Ginecol; 2004 Apr; 56(2):131-6. PubMed ID: 15258541
[TBL] [Abstract][Full Text] [Related]
44. The effect of prothrombotic blood abnormalities on risk of deep vein thrombosis in users of hormone replacement therapy: a prospective case-control study.
Douketis JD; Julian JA; Crowther MA; Kearon C; Bates SM; Barone M; Piovella F; Middeldorp S; Prandoni P; Johnston M; Costantini L; Ginsberg JS
Clin Appl Thromb Hemost; 2011; 17(6):E106-13. PubMed ID: 21159708
[TBL] [Abstract][Full Text] [Related]
45. Endogenous oestradiol as a positive correlate of plasma fibrinogen among older postmenopausal women: a population-based study (the Three-City cohort study).
Canonico M; Brailly-Tabard S; Gaussem P; Setiao J; Rouaud O; Ryan J; Carcaillon L; Guiochon-Mantel A; Scarabin PY
Clin Endocrinol (Oxf); 2012 Dec; 77(6):905-10. PubMed ID: 22642405
[TBL] [Abstract][Full Text] [Related]
46. Hormone replacement therapy and increased plasma concentration of C-reactive protein.
Ridker PM; Hennekens CH; Rifai N; Buring JE; Manson JE
Circulation; 1999 Aug; 100(7):713-6. PubMed ID: 10449692
[TBL] [Abstract][Full Text] [Related]
47. Hormone-replacement therapy increases serum paraoxonase arylesterase activity in diabetic postmenopausal women.
Sutherland WH; Manning PJ; de Jong SA; Allum AR; Jones SD; Williams SM
Metabolism; 2001 Mar; 50(3):319-24. PubMed ID: 11230785
[TBL] [Abstract][Full Text] [Related]
48. Postmenopausal hormone use in women with acute coronary syndromes.
Parsons E; Newby LK; Bhapkar MV; Alexander KP; White HD; Shah SH; Bushnell CD; Califf RM;
J Womens Health (Larchmt); 2004 Oct; 13(8):863-71. PubMed ID: 15671702
[TBL] [Abstract][Full Text] [Related]
49. Recency and duration of postmenopausal hormone therapy: effects on bone mineral density and fracture risk in the National Osteoporosis Risk Assessment (NORA) study.
Barrett-Connor E; Wehren LE; Siris ES; Miller P; Chen YT; Abbott TA; Berger ML; Santora AC; Sherwood LM
Menopause; 2003; 10(5):412-9. PubMed ID: 14501602
[TBL] [Abstract][Full Text] [Related]
50. Homocysteine in postmenopausal women and the importance of hormone replacement therapy.
Mijatovic V; van der Mooren MJ
Clin Chem Lab Med; 2001 Aug; 39(8):764-7. PubMed ID: 11592448
[TBL] [Abstract][Full Text] [Related]
51. Physical activity, fibrinogen plasma level and gene polymorphisms in postmenopausal women.
Rauramaa R; Väisänen S; Nissinen A; Rankinen T; Penttilä I; Saarikoski S; Tuomilehto J; Gagnon J; Pérusse L; Bouchard C
Thromb Haemost; 1997 Aug; 78(2):840-4. PubMed ID: 9268181
[TBL] [Abstract][Full Text] [Related]
52. Effect of hormone replacement therapy on hemostatic variables in post-menopausal women.
Al-Farra HM; Al-Fahoum SK; Tabbaa MA
Saudi Med J; 2005 Dec; 26(12):1930-5. PubMed ID: 16380775
[TBL] [Abstract][Full Text] [Related]
53. Changes in sex hormone-binding globulin, insulin, and serum lipids in postmenopausal women on a low-fat, high-fiber diet combined with exercise.
Tymchuk CN; Tessler SB; Barnard RJ
Nutr Cancer; 2000; 38(2):158-62. PubMed ID: 11525592
[TBL] [Abstract][Full Text] [Related]
54. Effect of the cessation of long-term hormone replacement therapy on plasma plasminogen activator inhibitor-1 and fibrinogen.
Kalela A; Jokela H; Lehtimäki T; Uppa H; Kunnas T; Teisala K; Punnonen R; Nikkari ST
Eur J Obstet Gynecol Reprod Biol; 2006 Apr; 125(2):217-20. PubMed ID: 16337074
[TBL] [Abstract][Full Text] [Related]
55. The effects of hormone replacement therapy and raloxifene on C-reactive protein and homocysteine in healthy postmenopausal women: a randomized, controlled trial.
Walsh BW; Paul S; Wild RA; Dean RA; Tracy RP; Cox DA; Anderson PW
J Clin Endocrinol Metab; 2000 Jan; 85(1):214-8. PubMed ID: 10634389
[TBL] [Abstract][Full Text] [Related]
56. Physical exercise and vasomotor symptoms in postmenopausal women.
Ivarsson T; Spetz AC; Hammar M
Maturitas; 1998 Jun; 29(2):139-46. PubMed ID: 9651903
[TBL] [Abstract][Full Text] [Related]
57. Hormone replacement therapy improves cardiovascular risk by lowering plasma viscosity in postmenopausal women.
Rosenson RS; Tangney CC; Mosca LJ
Arterioscler Thromb Vasc Biol; 1998 Dec; 18(12):1902-5. PubMed ID: 9848882
[TBL] [Abstract][Full Text] [Related]
58. Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. The Atherosclerosis Risk in Communities Study Investigators.
Nabulsi AA; Folsom AR; White A; Patsch W; Heiss G; Wu KK; Szklo M
N Engl J Med; 1993 Apr; 328(15):1069-75. PubMed ID: 8384316
[TBL] [Abstract][Full Text] [Related]
59. The effects of hormone replacement therapy on postmenopausal breast cancer biology and survival.
Sener SF; Winchester DJ; Winchester DP; Du H; Barrera E; Bilimoria M; Krantz S; Rabbitt S
Am J Surg; 2009 Mar; 197(3):403-7. PubMed ID: 19245923
[TBL] [Abstract][Full Text] [Related]
60. Effects of hormonal replacement therapy on plasma sex hormone-binding globulin, androgen and insulin-like growth factor-1 levels in postmenopausal women.
Stomati M; Hartmann B; Spinetti A; Mailand D; Rubino S; Albrecht A; Huber J; Petraglia F; Genazzani AR
J Endocrinol Invest; 1996 Sep; 19(8):535-41. PubMed ID: 8905477
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
